chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Body pain; pain in the left armpit glands; pain and swelling of the right armpit glands; body joint pain; Fever; Chills; Tiredness; loss of appetite; muscle pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 05Jan2022 13:30 (Lot number: 30025BD) at the age of 51 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Allergy" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 2, SINGLE, lot number: EW0187, Location: right arm), administration date: 07Jun2021, when the patient was 50 years old, for COVID-19 immunization; Bnt162b2 (DOSE 1, SINGLE, lot number: EW0175, location: right arm), administration date: 17May2021, when the patient was 50 years old, for COVID-19 immunization. The following information was reported: PAIN (non-serious) with onset 05Jan2022 16:30, outcome "recovering", described as "Body pain"; AXILLARY PAIN (non-serious) with onset 05Jan2022 16:30, outcome "recovering", described as "pain in the left armpit glands"; LYMPHADENOPATHY (non-serious) with onset 05Jan2022 16:30, outcome "recovering", described as "pain and swelling of the right armpit glands"; ARTHRALGIA (non-serious) with onset 05Jan2022 16:30, outcome "recovering", described as "body joint pain"; PYREXIA (non-serious) with onset 05Jan2022 16:30, outcome "recovering", described as "Fever"; CHILLS (non-serious) with onset 05Jan2022 16:30, outcome "recovering", described as "Chills"; FATIGUE (non-serious) with onset 05Jan2022 16:30, outcome "recovering", described as "Tiredness"; DECREASED APPETITE (non-serious) with onset 05Jan2022 16:30, outcome "recovering", described as "loss of appetite"; MYALGIA (non-serious) with onset 05Jan2022 16:30, outcome "recovering", described as "muscle pain". Therapeutic measures were not taken as a result of pain, axillary pain, lymphadenopathy, arthralgia, pyrexia, chills, fatigue, decreased appetite, myalgia.  Additional information: The did not receive any other vaccine in four weeks and also not received other medications in two weeks. The patient did not have covid prior to the vaccination and had not been tested for covid post vaccination.  No follow-up attempts are possible. No further information is expected.
Information has been received from a physician concerning a 7 year old patient who on unspecified dates was vaccinated with two doses of VARIVAX (Merck) (Lot # not reported). The physician reported that he examined the patient on 29-SEP-2010 and diagnosed chickenpox. The patient had been exposed to a grandfather with shingles. The patient's outcome was not reported. Follow-up information was received from a medical assistant who stated that they did not know who the patient was. No further information is available.
I have been experiencing left eyelid twitching that started approximately 1 week after getting the shot (11/11/21). I have been having heart fluttering for the last few days starting on 11/15/21 with feelings of anxiety. I usually never get anxiety out of the blue this happens when the heart starts to flutter.  I have not mentioned my symptoms to my doctor yet.
I received the TDAP shot, & afterwards I experienced the regular soreness, however after a week or so it got worse, & the pain in my shoulder was severe, & continued for over a month after I received the vaccine.  The pain was fairly constant, whether I was using my arm or it was at rest, the pain was still excruciating.  It hurt to put any pressure on my shoulder area, & I could not lift my arm above my head.  During the first week it helped if I massaged the area, but in weeks after that, the pain was so deep in my arm I couldn't get to it.  The pain continued to get worse until 4 weeks after the shot it started to slowly subside.  It has gotten mostly better, but still hurts occasionally even now, although it's getting more rare.
Patient was given both Vaxelis and Hib vaccinations. No adverse reactions reported by parents.
began having chest pain/ tightness and short of breath on exertion, elevated heart rate and blood pressure. No issues prior to vaccination  outcome- enlarged pulmonary artery (  had no prior heart issues)
Client received the 1st dose of Moderna COVID vaccine lot # 017C21A and expiration date 5/23/21 at 11:17am.  Client reports to EMT, that after waiting 30 minutes her "stomach feels funky" and nausea. EMT alert PHN.  Client was provided with emesis bag, crackers and water. PHN approached client sitting upright in chair alert and oriented x4 at 11:49AM.  Per client feeling clammy hands and nauseated.  Vitals at 11:48AM: blood pressure:183/117 , oxygen: 99% and pulse88. Retake blood pressure and similar reading of 184/118. At 11:51am, PHN called 911 since blood pressure was so high and client reports no previous history, client also reports feeling "hot and clammy hands". Client reports no headache, no blurred vision ,no dizziness, and no chest pain.  Client reports she has no medical history and takes no medications. At 11:57am, vitals: blood pressure :unable to get due to shakiness, oxygen: 97% and pulse:52. Client reports no changes in nausea. Client reports feeling "shaky and hot".  At 11:58am paramedics assume care.  At 12:07pm, client declined to leave with paramedics, client stayed a few more minutes in observation.  At 12:13pm client reports less nauseated and shaking has improved.  At 12:16pm vitals: blood pressure:130/86, oxygen:98%, and pulse:76.  At 12:18PM client left facility with a steady gait
Her sugars have been high; tenderness; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (tenderness) and BLOOD GLUCOSE INCREASED (Her sugars have been high) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetic.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced TENDERNESS (tenderness). On an unknown date, the patient experienced BLOOD GLUCOSE INCREASED (Her sugars have been high). At the time of the report, TENDERNESS (tenderness) and BLOOD GLUCOSE INCREASED (Her sugars have been high) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment medication - Tylenol   Reporter did not allow further contact
10 Scattered lesions, crusted vesicles, throughout body; few red papules in different forms throughout body.
PT HAS NOT REPORTED ANY ADVERSE EVENT.  PFIZER INDICATED THE MANUFATURER EXPIRATION DATE FOR THE VACCINE WAS 9/30/22 AND THE DOSE WAS ADMINISTERED ON 10/4/2022. PFIZER HAS INDICATED THAT THERE IS STABILITY DATA TO SUPPORT ITS USE UNTIL 10/19/2022. COMPLETING VAERS AT REQUEST OF CORPORATE DIRECTION.
Patient said that after vaccination he broke out in a rash (between his fingers and behind his knees) and was itching
The pt experienced 2 seizures, total of 2 at 15 minutes apart. The 1st seizure lasted 20-30 seconds and 2nd seizure lasted 5-10 seconds.
Rheumatoid Arthritis; a 23 years old patient  /  received the 1st dose of Shingrix in another facility; This case was reported by a pharmacist via call center representative and described the occurrence of rheumatoid arthritis in a 23-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included tofacitinib citrate (Xeljanz).   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced rheumatoid arthritis (serious criteria GSK medically significant) and inappropriate age at vaccine administration. On an unknown date, the outcome of the rheumatoid arthritis and inappropriate age at vaccine administration were unknown.   It was unknown if the reporter considered the rheumatoid arthritis to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient with rheumatoid arthritis received the 1st dose of Shingrix. The patient was currently taking Xeljaiz. The patient did not consent to follow-up.
red; warm site reactions; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 75-year-old female patient who received Flu unspecified (Flu vaccine) for prophylaxis.   Previously administered products included hepatitis B (received 1st dose on an unknown date), hepatitis B (received 2nd  dose on an unknown date) and hepatitis B with an associated reaction of erythema (received 3rd dose on an unknown date).   On an unknown date, the patient received Flu vaccine at an unknown dose. On an unknown date, unknown after receiving Flu vaccine, the patient experienced injection site erythema and injection site warmth. On an unknown date, the outcome of the injection site erythema and injection site warmth were unknown.   It was unknown if the reporter considered the injection site erythema and injection site warmth to be related to Flu vaccine.  Additional details were provided as follows: The patient received Flu vaccine and had erythema and feeling of warmth. This case linked with US2019186993 and US2019AMR192366, reported by same reporter for the same patient.
Started with chills pretty shortly after the vaccine was injected.  After about 6 hours I could tell I was not feeling great.  My husband said I looked very pale and out of it all of the sudden.  I became extremely tired and disoriented.  I don?t remember driving myself home that evening after picking up my kids from dance.  By the time I was home it was now around 8 pm.  I was so cold my entire body was trembling.  I kept taking steaming hot showers but I couldn?t feel it, I was still freezing and shaking.  I was very weak and started having extremely horrible body aches and pains.  Specifically my legs were hurting the worst, I remember my hip joints felt like they?d buckle underneath me.  I got a headache that was unbearable.  It felt worse than a migraine.  It hurt to move my head or use my eyes at all.  I went to bed and was under several blankets and a heating pad while also running a space heater right next to me.  I still could not get warm at all.  I hallucinated that I could see each ache and pain on my body and watched them move through me.  By 4 am I was now hysterical and crying.  I was in so much unbearable pain and so scared.  I had to call off of work for this day.  I was so out of it I called my daughter off of school but also called for my mom to come get her and take her to school.  I kept my youngest home with me.  My head was still the absolute worst headache I have ever felt in my life.  I couldn?t open my eyes and it hurt to move at all.  I had to call a friend to come pick up my youngest daughter because I was unable to take care of her, I could barely stay awake and alert.  I tried another hot shower and everything still felt cold.  I was now nauseous from the head pain.  Around noon on this day I finally had the strength to drink some water and was able to take Tylenol.  I laid on the couch for hours still shivering and in unbearable pain.  I was still very scared that I was having such a bad reaction that I would die.  I called my husband to come home from work and be with me because I was scared.  I took more Tylenol a couple hours after the first dose.  Around 6 pm I started to feel better.  I was able to eat again that evening.  I had a headache though for about 3 weeks after that gradually weaned away.
Information has been received from a physician concerning a patient who on 11-MAY-2007 was vaccinated with a dose of Zostavax (Oka/Merck). On 11-MAY-2007 the patient developed redness at the injection site. No other symptoms were noted. Unspecified medical attention was sought. a
w/in 20min of vax devel gen wheals, erythema of ears & face;progressed to diff breathing, near collapse;taken to MD office , then on to ER:pending ER report has signed ROI;
received the adult dose of Engerix-B; received the adult dose of Engerix-B; This case was reported by a other health professional via call center representative and described the occurrence of adult product administered to child in a 8-year-old female patient who received HBV (Engerix B adult) (batch number 94dj5, expiry date 15th December 2022) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 21st September 2021, the patient received the 2nd dose of Engerix B adult (intramuscular) and Engerix B Pre-Filled Syringe Device. On 21st September 2021, unknown after receiving Engerix B adult and Engerix B Pre-Filled Syringe Device, the patient experienced adult product administered to child and accidental overdose. On an unknown date, the outcome of the adult product administered to child and accidental overdose were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were reported as follows: The age at vaccination was not reported. A healthcare provider reported that a patient inadvertently received the adult dose of Engerix-B in the left deltoid which led to product administered to child and overdose. The reporter consented to follow up. The case had been linked with US2021199870 reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021199870:Same reporter
Onset included swelling of lymph nodes and glands in throat that got progressively worse over 2.5 weeks. In addition to the gland swelling I developed excruciating back pain and a low-grade temp. Although I only had a low grade temp, I felt like I had an extremely high fever. All blood work looked normal, but the back pain was intense and I was prescribed oral hydromorphone. The fourth week of the ongoing reaction I lost my voice, which required a shot of depo-medrol to start to get my voice back. It took 6 weeks before I felt back to normal.
Dedifferentiated retroperitoneal liposarcoma. High DHEA Sulfate test on 5/3/21 prompted doctor to order MRI abdomen without contrast on 5/22/21. Results noted peritoneal thickening and stranding in left quadrant with 4.7x7.3 cm mass (not reported by interpreting radiologist but seen by interpreting radiologist of later MRI when comparing dated images). Upon continued abdominal discomfort, referred for abdominal MRI with and without contrast 1/16/22. Easily observed retroperitoneal mass surrounding left kidney measuring 14.5x11x22 cm. Resection completed 2/4/22. No chemo or radiation prescribed. Tumor statistically highly likely to reoccur. Genetic testing completed May 2022 found no genetic predisposition for sarcoma. Not positive tumor occurred due to vaccination, but aggressive growth observed between May-January after vaccination in March and April warrants investigation.
Fever of 101, aches, dizziness and nausea.  Still had symptoms on tuesday except for fever.  Patient said he had the 2009 H1N1 in July and said he doesn't believe he had it a second time. He added that his head felt numb and his arm hurt at injection site and is still tender now.
anxious; dizziness; can't eat anything; nauseous; achiness all over the body; fever; diarrhea, on and off diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea, on and off diarrhea), ANXIETY (anxious), DIZZINESS (dizziness), FEEDING DISORDER (can't eat anything) and NAUSEA (nauseous) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included VENLAFAXINE HYDROCHLORIDE (EFFEXOR) for Depression.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced DIARRHOEA (diarrhea, on and off diarrhea), MYALGIA (achiness all over the body) and PYREXIA (fever). On 17-Jan-2021, the patient experienced ANXIETY (anxious), DIZZINESS (dizziness), FEEDING DISORDER (can't eat anything) and NAUSEA (nauseous). On 15-Jan-2021, MYALGIA (achiness all over the body) and PYREXIA (fever) had resolved. At the time of the report, DIARRHOEA (diarrhea, on and off diarrhea), ANXIETY (anxious), DIZZINESS (dizziness), FEEDING DISORDER (can't eat anything) and NAUSEA (nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       patient took Pepto-Bismol to treat nausea and diarrhea symptoms.
a little nauseous; chills; headache; feeling like he is getting the flu; body aches; This is a spontaneous report from a non-contactable consumer (Patient wife). A 78 years old male patient received first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 07Jan2021 at unspecified age at single dose for COVID-19 vaccination. The patient medical history and concomitant medications were not reported. The patient began with side effects last night on 12Jan2021. He was feeling a little nauseous, chills, headache. The patient was feeling like he was getting the flu. She didn't think he was running a fever and didn't feel like he was burning up or anything, just body aches. The caller wonder whether the side effects related to the vaccine or should he get tested, since the side effects were 5 days after the first dose and she didn't see any timeline for these reactions. The outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Week of administration:  Dizziness, near syncope, orthostatic hypotension, marked  weakness. May 2022:  Admitted with acute exacerbation of congestive heart failure, evidence of myocarditis, new onset of atrial fibrillation. June 2022:  Now on diuretics, amiodarone and having increased weakness, increased somnolence and markedly decreased intake July 2022:  Continued as above.  Symptoms of Guillian Barre with ascending paralysis, admitted on July 19, 2022 with evidence of continued myocarditis,  encephalitis, Guillian Barre symptoms, dysphagia August 2022:  Treatment with IVIG, high dose corticosteroids, diuretics, free water. Died August 9, 2022
19 hours post vaccination, sudden onset of dizziness and nausea, 1 episode of vomiting. Dizziness persisting.
Within approx. 3 min after receiving injections pt bilat ankles and feet developed macular rash and a band of redness developed around each ankle. Bottom of feet turned purple. Resolved on its own within approx. 15 minutes with treatment.
1st and 2nd day after shot had muscle aches, fatigue, headache, laid in bed for most of day.
Patient had a burning pain in her spine within 5 minutes of getting the Moderna shot; Patient had strong pain in her spine that went up to her head; Patient had strong pain in her spine that went up to her head; This spontaneous case was reported by a pharmacist and describes the occurrence of BURNING SENSATION (Patient had a burning pain in her spine within 5 minutes of getting the Moderna shot), SPINAL PAIN (Patient had strong pain in her spine that went up to her head) and HEADACHE (Patient had strong pain in her spine that went up to her head) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     Concurrent medical conditions included Immunocompromised.    On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced BURNING SENSATION (Patient had a burning pain in her spine within 5 minutes of getting the Moderna shot), SPINAL PAIN (Patient had strong pain in her spine that went up to her head) and HEADACHE (Patient had strong pain in her spine that went up to her head). At the time of the report, BURNING SENSATION (Patient had a burning pain in her spine within 5 minutes of getting the Moderna shot), SPINAL PAIN (Patient had strong pain in her spine that went up to her head) and HEADACHE (Patient had strong pain in her spine that went up to her head) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided.  The patient started treatment on an unspecified date with Moderna COVID-19 vaccine at dose 2 for an unspecified indication. The patient had a burning pain in spine within 5 minutes of getting the Moderna shot.  It was reported that patient's doctor and her neurologist said she should not take any m-RNA vaccine longer.  No treatment medication were provided.
had Covid; had Covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "had Covid". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: she and her husband had Covid. Therapeutic measures were taken as a result of drug ineffective, covid-19. Caller was prescribed with Paxlovid. Caller states before she realizes, she and her husband had Covid, they got their second booster dose on Sunday. Caller states that she is getting her first dose of Paxlovid. Caller wants to know any information if it (Paxlovid) will reduce the effect of the Pfizer Covid-19 booster.Efficacy in Subjects at High Risk of Progressing to Severe COVID-19 Illnes.The clinical study excluded individuals with a history of vaccination.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200786507 Same reporter/product/event, different patient
Numbness in R hand, pinky and ring finger to start, woke up in middle of night.  Continued, then L had, pinky and ring finger.  Numbness and tingling continued to migrate through out the body, bilat arms with numbness and weakness, hands weakness. Legs and toes, numbness, tingling and weakness.  Numbness wakes person in the middle of the night. Night sweats also started at same time and have continued.  Currently almost 6 months out, lingerling on and off numbness/tingling in leg, occasional numbness in hands.  Weakness for most part has passed.  None of these happened ever before the injection